Browsing byAuthorClark, K

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 51 to 64 of 64< previous 
Issue DateTitleAuthor(s)
2012-01-01Re: Oral docusate in the management of constipation in hospice patientsClark, K; Currow, DC
2020-05Response to Davies A, Leach C, Caponero R, Dickman A, Fuchs D, Paice J, Emmanuel A (2020) MASCC recommendations on the management of constipation in patients with advanced cancer. Support Care Cancer 28:23.Clark, K; Currow, DC
2011-11-01A retrospective analysis of primary diagnosis, comorbidities, anticholinergic load, and other factors on treatment for noisy respiratory secretions at the end of lifeSheehan, C; Clark, K; Lam, L; Chye, R
2013-07-01The role of benzodiazepines in breathlessness: A single site, open label pilot of sustained release morphine together with clonazepamAllcroft, P; Margitanovic, V; Greene, A; Agar, MR; Clark, K; Abernethy, AP; Currow, DC
2012-11-01The role of ondansetron in the management of cholestatic or uremic pruritus - A systematic reviewTo, THM; Clark, K; Lam, L; Shelby-James, T; Currow, DC
2015-10-01Routine prescribing of gabapentin or pregabalin in supportive and palliative care: what are the comparative performances of the medications in a palliative care population?Clark, K; Quinn, SJ; Doogue, M; Sanderson, C; Lovell, M; Currow, DC
2019-01-01Sertraline in symptomatic chronic breathlessness: a double blind, randomised trialCurrow, DC; Ekström, M; Louw, S; Hill, J; Fazekas, B; Clark, K; Davidson, PM; McDonald, C; Sajkov, D; McCaffrey, N; Doogue, M; Abernethy, AP; Agar, M
2016-11-01Study protocol: A phase III randomised, double-blind, parallel arm, stratified, block randomised, placebo-controlled trial investigating the clinical effect and cost-effectiveness of sertraline for the palliative relief of breathlessness in people with chronic breathlessnessWatts, GJ; Clark, K; Agar, M; Davidson, PM; McDonald, C; Lam, LT; Sajkov, D; McCaffrey, N; Doogue, M; Abernethy, AP; Currow, DC
2012-01-01Subsidised use of methylnaltrexone in Australia for palliative care.Rowett, DS; Clark, K; Robinson, MK; Currow, DC
2012-03-01Treating Constipation in Palliative Care: The Impact of Other Factors Aside From OpioidsClark, K; Byfieldt, N; Dawe, M; Currow, DC
2013-03-01Uptake of methylnaltrexone in Australian patients with opioid-induced constipation: a review of the number of prescriptions presented in the first 12 months of subsidisationClark, K; Rowett, D; Robinson, M; Currow, DC
2016-10-03Using opioids in general practice for chronic non-cancer pain: an overview of current evidenceCurrow, DC; Phillips, J; Clark, K
2016-05-02Using opioids in general practice for chronic non-cancer pain: An overview of current evidenceCurrow, DC; Phillips, J; Clark, K
2023-07Wearable-Triggered Ecological Momentary Assessments Are Feasible in People With Advanced Cancer and Their Family Caregivers: Feasibility Study from an Outpatient Palliative Care Clinic at a Cancer Center.Schuler, T; King, C; Matsveru, T; Back, M; Clark, K; Chin, D; Lilian, R; Gallego, B; Coiera, E; Currow, DC